Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Twelfth approval for Abelcet

Nov. 15, 1996

NDA filed for AmBisome

Nov. 15, 1996

ASA + ibuprofen combination effective in treating Listeria infection in mice

Nov. 15, 1996

Novel antibacterial compound from Banyu

Nov. 15, 1996

Agennix announces patent coverage for lactoferrin

Nov. 15, 1996

MiKasome cleared for clinical trials in HIV-positive patients

Nov. 8, 1996

Method for deriving ribozymes from nucleotide sequences available for licensing

Nov. 8, 1996

Northern Illinois University offers ribozyme with potential for treatment of HPV for licensing

Nov. 8, 1996

Hybridon files new patent for antisense oligonucleotides

Nov. 8, 1996

Potent inhibitor of HSV RR subunit association selected by Bio-Mega/Boehringer Ingelheim

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...